Custom eDC development & engineering
Develop an eDC line from customer-provided PBMCs, with antigen configuration and genetic modifications defined by the research project.
Projects may include gene knockout or other agreed genetic modifications. The project scope should specify the intended line, edit confirmation approach, functional assessment and delivered documentation.
PBMCs and research requirements
eDC line and agreed modifications
Confirmation and functional evidence
Start with a pilot
A pilot is scoped around one antigen, one HLA context and the decision the data should support. Controls, acceptance criteria and the reported limits are agreed before work begins, and the report states the tested configuration.
Scope
Question, antigen, HLA context, controls and acceptance criteria.
Pilot
A bounded study on an eDC configuration for your antigen.
Expand
Candidate panels, custom eDC lines or biologic screening, based on the pilot result.
Project workflow
Define
Research question, antigen, HLA context and requested modification, with a feasibility discussion before scope is agreed.
Provide
Customer PBMCs under agreed material and transfer requirements.
Develop
Custom eDC line and the agreed genetic modifications.
Characterize
Review agreed confirmation, functional evidence and deliverables.
Specify the project
| Customer input | Project definition |
|---|---|
| PBMC material | Source, quantity, handling and transfer requirements agreed before work |
| Antigen of interest | Expression requirements and relevant study context |
| Requested modification | Gene target and intended change, such as KO |
| Assay question | Relevant immune cell response or functional endpoint |
| Acceptance criteria | Agreed line characterization and modification confirmation |
| Controls | Matched control configuration and functional comparisons |
A customer supplies PBMCs and specifies an antigen plus a gene knockout. The project defines edit confirmation, antigen expression and the relevant functional readout. A matched engineered control, comparable culture conditions and APC/effector viability measurements help attribute any observed change.
Deliverables & scientific documentation
The delivered eDC line, genetic modifications and characterization package are defined in the project scope. Validation requirements should be matched to the intended experiment.
Items to request in the scope:
| Item | Ask for |
|---|---|
| Line identity | The eDC line and passage supplied |
| Antigen expression | The method and result confirming the intended antigen |
| Genetic modification | Confirmation of the requested edit, with the matched control |
| Phenotype | The marker panel and gating used |
| Functional readout | Assay conditions, controls and acceptance criteria |
| Handling | Culture, storage and transfer instructions |
Frequently asked questions
What material does the customer provide?
Customer PBMCs. Material requirements and transfer conditions are agreed for the project.
Can a project include a gene knockout?
Yes. Define the gene target, intended modification, confirmation method and relevant functional readout in the project scope.
How are timelines and feasibility established?
They are agreed after the requested configuration, material requirements and validation scope are reviewed.
Can a project start with a single question?
Yes. A pilot covers one antigen, HLA context and decision. The scope names the controls and acceptance criteria, and the next stage depends on the result.
Can eDCs be used to screen antibodies?
For immunomodulatory antibodies that act on APC targets such as CD40, eDCs can serve as the screening cell, once target expression is confirmed on the line. The scope defines the readouts, controls and assay-performance criteria.